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hemodialysis patientsTo the Editor:
Microparticles are small membrane vesicles that are released
from most cells such as platelets, leukocytes, lymphocytes,
erythrocytes, and endothelial cells [1]. There are many studies
on microparticles and vascular diseases, such as acute coronary
syndrome [2]. However, the exact roles of microparticles remain
unclear in kidney diseases, although there are characteristic
responses in various pathological processes, including inﬂam-
mation, immunity, and coagulopathy [3].
It was interesting that Ryu et al [4] reported the analysis of
microparticles in end-stage renal disease (ESRD) patients on
hemodialysis (HD). Considering that cardiovascular complica-
tions are the leading cause of ESRD, the role of microparticles
in thrombotic events in HD patients is important. Vascular
access patency is also very important for the maintenance of
dialysis as a lifeline for HD patients.
In their study, several confounding factors should have
been discussed when they compared the results between HD
patients and the healthy population. First of all, either the
dialysis procedure or vascular access use itself could affect the
level of microparticles in patient circulation in comparison
with the healthy population. The two groups may have had
different immunological, inﬂammatory, or coagulation condi-
tions, especially depending on the stage of the chronic kidney
disease. The patients with cardiac coronary stenting were
reported to have higher microparticle levels than those
treated with diagnostic catheterization alone [5]. Therefore,
it would be interesting to compare the healthy population and
predialysis patients. In addition, known risk factors, such as
age, diabetes, hypertension, smoking, and dyslipidemia, were
not completely excluded in this study.
The authors compared data of the microparticle levels
between groups B and C in terms of the duration of vascular
access patency. This trial was creative and interesting; how-
ever, the results presented in Table 3 raise a question regard-
ing why the microparticle levels between both groups were
not different, even though the patients in group B demon-
strated an older age, a higher incidence of diabetes, and lower
albumin and higher IL-6 levels than the group C (all p values
40.05). In contrast, Table 4 shows a difference in the micro-
particle level even among nondiabetic patients. Subgroup
analysis is also needed to analyze the diabetic patients. Other
confounding variables, including HD dose, duration, and
frequency, the membrane used, the on-line hemodiaﬁltration
characteristics, and the anticoagulation dose, need to be132/$ - see front matter
dx.doi.org/10.1016/j.krcp.2012.05.001compared between both groups. Neither arteriovenous ﬁstula
nor artiﬁcial graft use was described in either group. Finally, I
believe in the importance of the scaled assessment of vascular
function. This was not performed in this study, although the
authors mentioned its limitations in the Discussion.
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Dear Sir/Madam,
We appreciate your comments regarding our study. Your
concerns are summarized as follows: (1) various factors,
including mechanical factors, access type, dialysis type, dia-
lysis dose, types of membrane used, anticoagulation dose, and
dyslipidemia, were not included in our study; (2) the healthy
Kidney Res Clin Pract 31 (2012) 200–201 201control is not proper for comparison with ESRD patents; (3) in
Tables 3 and 4, the diabetic patients should be analyzed; and
(4) the scaled assessment of vascular function needs to be
performed.
First, mechanical factors such as hemodialysis per se,
vascular access, and the type of access may affect the
production of microparticles. One study reported that vascu-
lar shear stress determines the circulating levels of endothe-
lial microparticles in ESRD patients [1]. Another study
reported that the dialysis process induces endothelial activa-
tion and the generation of resting platelet-derived micropar-
ticles [2]. However, in order to minimize artiﬁcial endothelial
activation, the patients and healthy volunteers were required
to rest for at least 30 minutes prior to blood collection.
Furthermore, all of the patient samples were collected before
the dialysis session and 72 hours after the last dialysis
session. So, the mechanical effects might have been small.
The access type was native in 96.3% of patients, and this factor
might not have had a great impact on microparticle genera-
tion. When we analyzed the patients with native vascular
access, the results were not different in comparison with the
whole patients. We did not analyze the data from patients
who were undergoing on-line HDF. The frequency of dialysis
and the dose were determined using KT/V, and all of the
patients (except 2 patients) were receiving HD three times per
week. Polysulfone was the dialysis membrane in all patients.
We did not think that the heparin dose would affect the level
of the endothelial microparticles. However, these factors will
be considered as important variables in our future study.
Second, we agree that healthy controls without any data
regarding their medical histories should not be used as a
comparison with ESRD patients. We also think this is the
weak point of our study. However, we analyzed our data after
adjusting for age and diabetes in order to minimize the effects
of comorbidities in these patients (Figs. 3 and 4). We could
not exclude all of the confounding factors because of the
small number of included cases. The cholesterol levels
between the patients and controls were signiﬁcantly differ-
ent, but the mean levels were not compatible with the
deﬁnition of dyslipidemia (175 mg/dL in patients vs.
197 mg/dL in controls).Third, we did analyze the diabetic patients. The results are
similar to those presented in Table 3, and the endothelial
microparticle (EMP) and platelet microparticel (PMP) levels
between the short survival group (group B) and the long survival
group (group C) did not demonstrate a signiﬁcant difference in
diabetic patients. We have no explanation for why the EMP and
PMP levels were markedly increased in the nondiabetic group B.
However, this ﬁnding may indicate that increased levels of EMP
and PMP are important risk factors associated with vascular
access survival. However, the small number of cases (n¼5) is a
limitation of our study. Confounding factors should also be
included in future subgroup analyses.
Finally, we absolutely agree with your concern that a
scaled assessment of vascular function has to be performed.
In future studies, we will perform a scaled assessment of
access dysfunction.
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